Have a personal or library account? Click to login
A Systematic Review of the Spectrum of Cardiac Arrhythmias in Sub-Saharan Africa Cover

A Systematic Review of the Spectrum of Cardiac Arrhythmias in Sub-Saharan Africa

Open Access
|May 2020

References

  1. United Nations. World population prospects. The 2017 Revision 2017. https://esa.un.org/unpd/wpp/Publications/Files/WPP2017_KeyFindings.pdf.
  2. World Health Organization. Global health estimates 2016: Deaths by cause, age, sex, by country, and by region, 2000–2016 2018. https://www.who.int/healthinfo/global_burden_disease/estimates/en/index1.html.
  3. A systematic analysis for the Global Burden of Disease Study 2017. Default results are deaths and DALYs for 2017 with trends since 1990 2017. http://ghdx.healthdata.org/gbd-results-tool (accessed 20 March 2019).
  4. Mensah GA, Roth GA, Sampson UK, Moran AE, Feigin VL, Forouzanfar MH, et al. Mortality from cardiovascular diseases in sub-Saharan Africa, 1990–2013: A systematic analysis of data from the Global Burden of Disease Study 2013. Cardiovascular Journal of Africa. 2015; 26(2 Suppl 1): S610. DOI: 10.5830/CVJA-2015-036
  5. Keates AK, Mocumbi AO, Ntsekhe M, Sliwa K, Stewart S. Cardiovascular disease in Africa: Epidemiological profile and challenges. Nature reviews Cardiology. 2017; 14(5): 27393. DOI: 10.1038/nrcardio.2017.19
  6. Trowell HC. Non-infective Disease in Africa. The Peculiarities of Medical Non-infective Diseases in the Indigenous Inhabitants of Africa South of the Sahara. London: Edward Arnold; 1960.
  7. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS medicine. 2006; 3(11): e442. DOI: 10.1371/journal.pmed.0030442
  8. Jacobs MS, van Hulst M, Adeoye AM, Tieleman RG, Postma MJ, Owolabi MO. Atrial fibrillation in Africa—An under-reported and unrecognized risk factor for stroke: A systematic review. Global Heart. 2019; 14(3): 26979. DOI: 10.1016/j.gheart.2019.04.003
  9. Bonny A, Ngantcha M, Scholtz W, Chin A, Nel G, Anzouan-Kacou JB, et al. Cardiac arrhythmias in Africa: Epidemiology, management challenges, and perspectives. Journal of the American College of Cardiology. 2019; 73(1): 1009. DOI: 10.1016/j.jacc.2018.09.084
  10. Bestawros M. Electrophysiology in the developing world: Challenges and opportunities. Cardiology Clinics. 2017; 35(1): 4958. DOI: 10.1016/j.ccl.2016.09.002
  11. Talle MA, Bonny A, Scholtz W, Chin A, Nel G, Karaye KM, et al. Status of cardiac arrhythmia services in Africa in 2018: A PASCAR Sudden Cardiac Death Task Force report. Cardiovascular Journal of Africa. 2018; 29(2): 11521. DOI: 10.5830/CVJA-2018-027
  12. Bonny A, Ngantcha M, Jeilan M, Okello E, Kaviraj B, Talle MA, et al. Statistics on the use of cardiac electronic devices and interventional electrophysiological procedures in Africa from 2011 to 2016: Report of the Pan African Society of Cardiology (PASCAR) Cardiac Arrhythmias and Pacing Task Forces. Europace: European pacing, arrhythmias, and cardiac electrophysiology. Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. 2018; 20(9): 151326. DOI: 10.1093/europace/eux353
  13. Adedinsewo D, Omole O, Oluleye O, Ajuyah I, Kusumoto F. Arrhythmia care in Africa. Journal of Interventional Cardiac Electrophysiology: An International Journal of Arrhythmias and Pacing; 2018. DOI: 10.1007/s10840-018-0398-z
  14. Bonny A, Ngantcha M, Yuyun MF, Scholtz W, Karaye KM, Suliman A, et al. Cardiac arrhythmia services in Africa from 2011 to 2018: The second report from the Pan African Society of Cardiology working group on cardiac arrhythmias and pacing. Paris: ESC World Cardiology Congress; 2019. DOI: 10.1093/europace/euz354
  15. Koopman JJ, van Bodegom D, Westendorp RG, Jukema JW. Scarcity of atrial fibrillation in a traditional African population: A community-based study. BMC cardiovascular disorders. 2014; 14: 87. DOI: 10.1186/1471-2261-14-87
  16. Dewhurst MJ, Adams PC, Gray WK, Dewhurst F, Orega GP, Chaote P, et al. Strikingly low prevalence of atrial fibrillation in elderly Tanzanians. Journal of the American Geriatrics Society. 2012; 60(6): 113540. DOI: 10.1111/j.1532-5415.2012.03963.x
  17. Coulibaly I, Anzouan-Kacou JB, Konin KC, Kouadio SC, Abouo-N’Dori R. Medecine tropicale: Revue du Corps de sante colonial. Atrial fibrillation: Epidemiological data from the Cardiology Institute in Abidjan, Cote d’Ivoire. 2010; 70(4): 3714.
  18. Sliwa K, Carrington MJ, Klug E, Opie L, Lee G, Ball J, et al. Predisposing factors and incidence of newly diagnosed atrial fibrillation in an urban African community: Insights from the Heart of Soweto Study. Heart (British Cardiac Society). 2010; 96(23): 187882. DOI: 10.1136/hrt.2010.206938
  19. Mbaye A, Pessinaba S, Bodian M, Mouhamadou BN, Mbaye F, Kane A, et al. Atrial fibrillation, frequency, etiologic factors, evolution and treatment in a cardiology department in Dakar, Senegal. The Pan African Medical Journal. 2010; 6: 16.
  20. Coulibaly S, Diall IB, Menta I, Diakité M, Ba HO, Sibibé S, et al. Fibrillation atriale dans le service de Cardiologie du CHU du Point G: Clinique, facteurs etiologiques et evolution naturelle. [Atrial fibrillation in Cardiology Service of Point G Training Hospital: Clinical, etiologic factors, and natural evolution]. Cardiologie Tropicale; 2013.
  21. Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, Becker A, et al. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): A cohort study. Lancet (London, England). 2008; 371(9616): 91522. DOI: 10.1016/S0140-6736(08)60417-1
  22. Sani MU, Davison BA, Cotter G, Mayosi BM, Edwards C, Ogah OS, et al. Prevalence, clinical characteristics, and outcomes of valvular atrial fibrillation in a cohort of African patients with acute heart failure: Insights from the THESUS-HF registry. Cardiovascular Journal of Africa. 2018; 29(3): 13945. DOI: 10.5830/CVJA-2017-051
  23. Makubi A, Hage C, Lwakatare J, Kisenge P, Makani J, Ryden L, et al. Contemporary aetiology, clinical characteristics, and prognosis of adults with heart failure observed in a tertiary hospital in Tanzania: The prospective Tanzania Heart Failure (TaHeF) study. Heart (British Cardiac Society). 2014; 100(16): 123541. DOI: 10.1136/heartjnl-2014-305599
  24. Zuhlke L, Karthikeyan G, Engel ME, Rangarajan S, Mackie P, Cupido-Katya Mauff B, et al. Clinical outcomes in 3,343 children and adults with rheumatic heart disease from 14 low- and middle-income countries: Two-year follow-up of the Global Rheumatic Heart Disease Registry (the REMEDY Study). Circulation. 2016; 134(19): 145666. DOI: 10.1161/CIRCULATIONAHA.116.024769
  25. Okello E, Longenecker CT, Beaton A, Kamya MR, Lwabi P. Rheumatic heart disease in Uganda: Predictors of morbidity and mortality one year after presentation. BMC Cardiovascular Disorders. 2017; 17(1): 20. DOI: 10.1186/s12872-016-0451-8
  26. Sliwa K, Carrington M, Mayosi BM, Zigiriadis E, Mvungi R, Stewart S. Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: Insights from the heart of Soweto study. European Heart Journal. 2010; 31(6): 71927. DOI: 10.1093/eurheartj/ehp530
  27. Syed FF, Ntsekhe M, Wiysonge CS, Badri M, Oh JK, Mayosi BM. Atrial fibrillation as a consequence of tuberculous pericardial effusion. International Journal of Cardiology. 2012; 158(1): 1524. DOI: 10.1016/j.ijcard.2012.04.075
  28. Mansoor E. De novo atrial fibrillation post cardiac surgery: The Durban experience. Cardiovascular Journal of Africa. 2014; 25(6): 2827. DOI: 10.5830/CVJA-2014-067
  29. Nqayana T, Moodley J, Naidoo DP. Cardiac disease in pregnancy. Cardiovascular Journal of Africa. 2008; 19(3): 14551.
  30. Alkali NH, Bwala SA, Akano AO, Osi-Ogbu O, Alabi P, Ayeni OA. Stroke risk factors, subtypes, and 30-day case fatality in Abuja, Nigeria. Nigerian Medical Journal: Journal of the Nigeria Medical Association. 2013; 54(2): 12935. DOI: 10.4103/0300-1652.110051
  31. Walker RW, Dewhurst M, Gray WK, Jusabani A, Aris E, Unwin N, et al. Electrocardiographic assessment of coronary artery disease and stroke risk factors in rural and urban Tanzania: A case-control study. Journal of Stroke and Cerebrovascular Diseases: The Official Journal of National Stroke Association. 2014; 23(2): 31520. DOI: 10.1016/j.jstrokecerebrovasdis.2013.03.002
  32. Lekoubou A, Nkoke C, Dzudie A, Kengne AP. Recurrent stroke and early mortality in an urban medical unit in Cameroon. Journal of Stroke and Cerebrovascular Diseases: The Official Journal of National Stroke Association. 2017; 26(8): 168994. DOI: 10.1016/j.jstrokecerebrovasdis.2017.03.031
  33. Adeoye AM, Ogah OS, Ovbiagele B, Akinyemi R, Shidali V, Agyekum F, et al. Prevalence and prognostic features of ECG abnormalities in acute stroke: Findings from the SIREN Study Among Africans. Global Heart. 2017; 12(2): 99105. DOI: 10.1016/j.gheart.2017.01.002
  34. Ebrahim I, Bryer A, Cohen K, Mouton JP, Msemburi W, Blockman M. Poor anticoagulation control in patients taking warfarin at a tertiary and district-level prothrombin clinic in Cape Town, South Africa. Suid-Afrikaanse tydskrif vir geneeskunde. [South African Medical Journal]. 2018; 108(6): 4904. DOI: 10.7196/SAMJ.2018.v108i6.13062
  35. Anakwue R, Ocheni S, Madu A. Utilization of oral anticoagulation in a teaching hospital in Nigeria. Annals of Medical and Health Sciences Research. 2014; 4(Suppl 3): S28690. DOI: 10.4103/2141-9248.141973
  36. Sonuga BO, Hellenberg DA, Cupido CS, Jaeger C. Profile and anticoagulation outcomes of patients on warfarin therapy in an urban hospital in Cape Town, South Africa. African Journal of Primary Health Care & Family Medicine. 2016; 8(1): e18. DOI: 10.4102/phcfm.v8i1.1032
  37. Shavadia J, Yonga G, Mwanzi S, Jinah A, Moriasi A, Otieno H. Clinical characteristics and outcomes of atrial fibrillation and flutter at the Aga Khan University Hospital, Nairobi. Cardiovascular Journal of Africa. 2013; 24(2): 69. DOI: 10.5830/CVJA-2012-064
  38. Ntep-Gweth M, Zimmermann M, Meiltz A, Kingue S, Ndobo P, Urban P, et al. Atrial fibrillation in Africa: Clinical characteristics, prognosis, and adherence to guidelines in Cameroon. Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. 2010; 12(4): 4827. DOI: 10.1093/europace/euq006
  39. Jardine RM, Fine J, Obel IW. A survey on the treatment of atrial fibrillation in South Africa. Suid-Afrikaanse tydskrif vir geneeskunde. [South African medical journal]. 2014; 104(9): 6237. DOI: 10.7196/SAMJ.8111
  40. Mandi DG, Samadoulougou AK, Yameogo RA, Millogo GRC, Naibe DT, Hervé KPK, et al. Non valvular atrial fibrillation related ischaemic stroke at the Teaching Hospital of Yalgado Ouédraogo, Burkina Faso. N J Vasc Med Surg. 2015; 3. DOI: 10.4172/2329-6925.1000171
  41. Oldgren J, Healey JS, Ezekowitz M, Commerford P, Avezum A, Pais P, et al. Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: The RE-LY Atrial Fibrillation Registry. Circulation. 2014; 129(15): 156876. DOI: 10.1161/CIRCULATIONAHA.113.005451
  42. Mbolla BF, Gombet TR, Ikama MS, Bassemouka LD, Kimbally-Kaky G, Ekoba J, et al. Fibrillation auriculaire a propos de 131 cas congolais. Med Afr Noire. 2006; 53(2): 738.
  43. Lugero C, Kibirige D, Kayima J, Mondo CK, Freers J. Atrial fibrillation among the black population in a Ugandan tertiary hospital. International Journal of General Medicine. 2016; 9: 1918. DOI: 10.2147/IJGM.S100637
  44. Akpa MR, Ofori S. Atrial fibrillation: An analysis of etiology and management pattern in a tertiary hospital in Port-harcourt, southern Nigeria. Res J of Health Sci. 2015; 3(4): 3030.
  45. Yameogo AR, Kologo JK, Mandi G, Kabore HP, Millogo GR, Seghda AA, et al. Use of Vitamins K antagonists in non-valvular atrial fibrillation thromboembolic risk prevention in Burkina Faso. The Pan African Medical Journal. 2016; 24: 108. DOI: 10.11604/pamj.2016.24.108.7100
  46. Mapoure YN, Kamdem F, Akeyeh FJ, Dzudie A, Mouliom S, Mouelle AS, et al. Cardio-embolic stroke: Lessons from a single centre in sub-Saharan Africa. Revue Neurologique; 2019. DOI: 10.1016/j.neurol.2019.02.004
  47. Healey JS, Oldgren J, Ezekowitz M, Zhu J, Pais P, Wang J, et al. Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: A cohort study. Lancet (London, England). 2016; 388(10050): 11619. DOI: 10.1016/S0140-6736(16)30968-0
  48. Temu TM, Lane KA, Shen C, Ng’ang’a L, Akwanalo CO, Chen PS, et al. Clinical characteristics and 12-month outcomes of patients with valvular and non-valvular atrial fibrillation in Kenya. PloS One. 2017; 12(9): e0185204. DOI: 10.1371/journal.pone.0185204
  49. Mwita JC, Ocampo C, Molefe-Baikai OJ, Goepamang M, Botsile E, Tshikuka JG. Characteristics and 12-month outcome of patients with atrial fibrillation at a tertiary hospital in Botswana. Cardiovascular Journal of Africa. 2019; 30: 17. DOI: 10.5830/CVJA-2019-013
  50. Thomas V, Schulein S, Millar RN, Mayosi BM. Clinical characteristics and outcome of lone atrial fibrillation at a tertiary referral centre: The Groote Schuur Hospital experience. Cardiovascular Journal of Africa. 2018; 29(5): 26872. DOI: 10.5830/CVJA-2018-005
  51. Muthalaly RG, Koplan BA, Albano A, North C, Campbell JI, Kakuhikire B, et al. Low population prevalence of atrial fibrillation in rural Uganda: A community-based cross-sectional study. International Journal of Cardiology. 2018; 271: 8791. DOI: 10.1016/j.ijcard.2018.05.074
  52. Greffie ES, Mitiku T, Getahun S. High prevalence of atrial fibrillation in stroke patients admitted to University of Gondar Hospital, Northwest Ethiopia. Ethiopian Medical Journal. 2016; 54(4): 20712.
  53. Ajayi EA, Adeyeye VO, Adeoti AO. Clinical and echocardiographic profile of patients with atrial fibrillation in Nigeria. Journal of Health Science. 2016; 6(3): 3742.
  54. Bhagat K, Tisocki K. Prescribing patterns for the use of antithrombotics in the management of atrial fibrillation in Zimbabwe. The Central African Journal of Medicine. 1999; 45(11): 28790. DOI: 10.4314/cajm.v45i11.8501
  55. Van der Merwe DM, Van der Merwe PL. Supraventricular tachycardia in children. Cardiovascular Journal of South Africa: Official Journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners. 2004; 15(2): 649.
  56. Millar RN, Milne DA, von Oppell UO, Reichart B. Surgery for the Wolff-Parkinson-White syndrome. The Groote Schuur Hospital experience. Suid-Afrikaanse tydskrif vir geneeskunde. [South African Medical Journal]. 1991; 79(10): 5837.
  57. Edwards-Jackson N, North K, Chiume M, Nakanga W, Schubert C, Hathcock A, et al. Outcomes of in-hospital paediatric cardiac arrest from a tertiary hospital in a low-income African country. Paediatrics and International Child Health. 2019: 15. DOI: 10.1080/20469047.2019.1570443
  58. Ngunga LM, Yonga G, Wachira B, Ezekowitz JA. Initial rhythm and resuscitation outcomes for patients developing cardiac arrest in hospital: Data from low-middle income country. Global Heart. 2018; 13(4): 25560. DOI: 10.1016/j.gheart.2018.07.001
  59. Bonny A, Tibazarwa K, Mbouh S, Wa J, Fonga R, Saka C, et al. Epidemiology of sudden cardiac death in Cameroon: The first population-based cohort survey in sub-Saharan Africa. International Journal of Epidemiology. 2017; 46(4): 12308. DOI: 10.1093/ije/dyx043
  60. Adekola OO, Asiyanbi GK, Desalu I, Olatosi JO, Kushimo OT. The outcome of anaesthesia related cardiac arrest in a sub-Saharan tertiary hospital. Egyptian Journal of Anaesthesia. 2016; 32(3): 31521. DOI: 10.1016/j.egja.2016.04.002
  61. Talle MA, Bonny A, Bakki B, Buba F, Anjorin CO, Yusuph H, et al. Sudden cardiac death: Clinical perspectives from the University of Maiduguri Teaching Hospital, Nigeria. World Journal of Cardiovascular Diseases. 2015; 5: 95106. DOI: 10.4236/wjcd.2015.55013
  62. Akinwusi PO, Komolafe AO, Olayemi OO, Adeomi AA. Pattern of sudden death at Ladoke Akintola University of Technology Teaching Hospital, Osogbo, South West Nigeria. Vascular Health and Risk Management. 2013; 9: 3339. DOI: 10.2147/VHRM.S44923
  63. Kwari YD, Bello MR, Eni UE. Pattern of perioperative cardiac arrests at University of Maiduguri Teaching Hospital. Nigerian Journal of Medicine: Journal of the National Association of Resident Doctors of Nigeria. 2010; 19(2): 1736. DOI: 10.4314/njm.v19i2.56514
  64. Tiemensma M, Burger EH. Sudden and unexpected deaths in an adult population, Cape Town, South Africa, 2001–2005. Suid-Afrikaanse tydskrif vir geneeskunde. [South African medical journal]. 2012; 102(2): 904. DOI: 10.7196/SAMJ.5363
  65. Stein C. Out-of-hospital cardiac arrest cases in Johannesburg, South Africa: A first glimpse of short-term outcomes from a paramedic clinical learning database. Emergency Medicine Journal: EMJ. 2009; 26(9): 6704. DOI: 10.1136/emj.2008.066084
  66. Olotu A, Ndiritu M, Ismael M, Mohammed S, Mithwani S, Maitland K, et al. Characteristics and outcome of cardiopulmonary resuscitation in hospitalised African children. Resuscitation. 2009; 80(1): 6972. DOI: 10.1016/j.resuscitation.2008.09.019
  67. Rotimi O, Fatusi AO, Odesanmi WO. Sudden cardiac death in Nigerians—The Ile-Ife experience. West African Journal of Medicine. 2004; 23(1): 2731. DOI: 10.4314/wajm.v23i1.28076
  68. Rotimi O, Ajayi AA, Odesanmi WO. Sudden unexpected death from cardiac causes in Nigerians: A review of 50 autopsied cases. International Journal of Cardiology. 1998; 63(2): 1115. DOI: 10.1016/S0167-5273(97)00274-X
  69. Schneider J, Bezabih K. Causes of sudden death in Addis Ababa, Ethiopia. Ethiopian Medical Journal. 2001; 39(4): 32340.
  70. Arthur JT. Sudden deaths: Cardiac and non-cardiac in children in Accra. West African Journal of Medicine. 1995; 14(2): 10811.
  71. Vedanthan R, Fuster V, Fischer A. Sudden cardiac death in low- and middle-income countries. Global Heart. 2012; 7(4): 35360. DOI: 10.1016/j.gheart.2012.10.002
  72. Naidoo DP, Vythilingum S, Mitha AS. Ventricular arrhythmias in patients with severe aortic regurgitation. Cardiovascular Journal of Africa. 1993; 4(3): 1068.
  73. Mene-Afejuku TO, Balogun MO, Akintomide AO, Adebayo RA, Ajayi OE, Amadi VN, et al. Clinical and echocardiographic predictors of arrhythmias detected with 24-hour holter electrocardiography among hypertensive heart failure patients in Nigeria. Clinical Medicine Insights Cardiology. 2017; 11: 1179546817746632. DOI: 10.1177/1179546817746632
  74. Heradien M, Goosen A, Moolman-Smook JC, Brink PA. Race and gender representation of hypertrophic cardiomyopathy or long QT syndrome cases in a South African research setting. Cardiovascular Journal of Africa. 2007; 18(5): 3125.
  75. Cabral TT, Budzee A, Butera G. The first cardioverter defibrillator implanted in Central Africa. The Pan African Medical Journal. 2016; 23: 115. DOI: 10.11604/pamj.2016.23.115.3822
  76. Watkins DA, Hendricks N, Shaboodien G, Mbele M, Parker M, Vezi BZ, et al. Clinical features, survival experience, and profile of plakophylin-2 gene mutations in participants of the arrhythmogenic right ventricular cardiomyopathy registry of South Africa. Heart Rhythm. 2009; 6(11 Suppl): S107. DOI: 10.1016/j.hrthm.2009.08.018
  77. Mayosi BM, Fish M, Shaboodien G, Mastantuono E, Kraus S, Wieland T, et al. Identification of Cadherin 2 (CDH2) mutations in arrhythmogenic right ventricular cardiomyopathy. Circulation Cardiovascular Genetics. 2017; 10(2). DOI: 10.1161/CIRCGENETICS.116.001605
  78. Bonny A, Tonet J, Fontaine G, Lacotte J, Coignard E, Duthoit G, et al. Brugada syndrome in pure black Africans. Journal of Cardiovascular Electrophysiology. 2008; 19(4): 4216. DOI: 10.1111/j.1540-8167.2007.01041.x
  79. Aba YT, Fresard A, Gagneux-Brunon A, Lutz MF, Cazorla C, Lucht F, et al. Brugada syndrome revealed by intestinal shigellosis in a patient from Benin at the University Hospital of Saint-Etienne. Bulletin de la Societe de pathologie exotique (1990). 2017; 110(4): 2503. DOI: 10.1007/s13149-017-0575-9
  80. Blancard M, Debbiche A, Kato K, Cardin C, Sabrina G, Gandjbakhch E, et al. An African loss-of-function CACNA1C variant p.T1787M associated with a risk of ventricular fibrillation. Scientific Reports. 2018; 8(1): 14619. DOI: 10.1038/s41598-018-32867-4
  81. Bonny A, Noah DN, Amougou SN, Saka C. Prevalence and significance of early repolarisation in a black African population: Data of 246 individuals with cardiovascular morbidity. Cardiovascular Journal of Africa. 2013; 24(7): 2805. DOI: 10.5830/CVJA-2013-063
  82. Ilkhanoff L, Soliman EZ, Prineas RJ, Walsh JA, 3rd, Ning H, Liu K, et al. Clinical characteristics and outcomes associated with the natural history of early repolarization in a young, biracial cohort followed to middle age: The Coronary Artery Risk Development in Young Adults (CARDIA) study. Circulation Arrhythmia and Electrophysiology. 2014; 7(3): 3929. DOI: 10.1161/CIRCEP.113.000874
  83. Chin A. Sudden cardiac death in Africa. Cardiovascular Journal of Africa. 2014; 25(4): 1512.
  84. Peters F, Khandheria BK, dos Santos C, Matioda H, Maharaj N, Libhaber E, et al. Isolated left ventricular noncompaction in sub-Saharan Africa: A clinical and echocardiographic perspective. Circulation Cardiovascular Imaging. 2012; 5(2): 18793. DOI: 10.1161/CIRCIMAGING.111.966937
  85. Gaye ND, Ngaide AA, Bah MB, Babaka K, Mbaye A, Abdoul K. Non-compaction of left ventricular myocardium in sub-Saharan African adults. Heart Asia. 2017; 9(2): e010884. DOI: 10.1136/heartasia-2017-010884
  86. Paule P, Braem L, Mioulet D, Jop B, Theron A, Gil JM, et al. Left ventricular noncompaction: A cardiomyopathy in young individuals. Description of first cases in Africa. Medecine Tropicale: Revue du Corps de sante colonial. 2007; 67(6): 58793.
  87. Levin JSE, Harrisberg J, Govandrageloo K. Idiopathic long Q-T syndrome in a blackinfant. Cardiovasc J Afr. 1992; 3(3): 1446.
  88. Hedley PL, Durrheim GA, Hendricks F, Goosen A, Jespersgaard C, Stovring B, et al. Long QT syndrome in South Africa: The results of comprehensive genetic screening. Cardiovascular Journal of Africa. 2013; 24(6): 2317. DOI: 10.5830/CVJA-2013-032
  89. Kolo PM, Opadijo OG, Omotoso AB, Katibi IA, Balogun MO, Araoye MA. Prognostic significance of QT interval prolongation in adult Nigerians with chronic heart failure. Nigerian Journal of Clinical Practice. 2008; 11(4): 33641.
  90. Hoevelmann J, Viljoen CA, Manning K, Baard J, Hahnle L, Ntsekhe M, et al. The prognostic significance of the 12-lead ECG in peripartum cardiomyopathy. International Journal of Cardiology. 2019; 276: 17784. DOI: 10.1016/j.ijcard.2018.11.008
  91. Laher AE, Moolla M, Motara F, Paruk F, Richards G. Survival after cardiac arrest secondary to massive pulmonary embolism. Case Reports in Emergency Medicine. 2018; 2018: 8076808. DOI: 10.1155/2018/8076808
  92. Mayosi BM, Ntsekhe M, Bosch J, Pandie S, Jung H, Gumedze F, et al. Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis. The New England Journal of Medicine. 2014; 371(12): 112130. DOI: 10.1056/NEJMoa1407380
  93. Hidron A, Vogenthaler N, Santos-Preciado JI, Rodriguez-Morales AJ, Franco-Paredes C, Rassi A Jr. Cardiac involvement with parasitic infections. Clinical Microbiology Reviews. 2010; 23(2): 32449. DOI: 10.1128/CMR.00054-09
  94. Malvy D, Receveur MC, Ozon P, Djossou F, Le Metayer P, Touze JE, et al. Fatal cardiac incident after use of halofantrine. Journal of Travel Medicine. 2000; 7(4): 2156. DOI: 10.2310/7060.2000.00065
  95. Mocumbi AO, Falase AO. Recent advances in the epidemiology, diagnosis, and treatment of endomyocardial fibrosis in Africa. Heart (British Cardiac Society). 2013; 99(20): 14817. DOI: 10.1136/heartjnl-2012-303193
  96. Tantchou Tchoumi JC, Butera G, Giamberti A, Ambassa JC, Sadeu JC. Occurrence and pattern of congenital heart diseases in a rural area of sub-Saharan Africa. Cardiovascular Journal of Africa. 2011; 22(2): 636. DOI: 10.5830/CVJA-2010-046
  97. Olajumoke TO, Afolayan JM, Raji SA, Adekunle MA. Cardiopulmonry resuscitation—Knowledge, attitude & pratices in Osun State, Nigeira. Journal of the West African College of Surgeons. 2012; 2(2): 2332.
  98. Sadoh WE, Osariogiagbon W. Knowledge and practice of cardiopulmonary resuscitation amongst doctors and nurses in Benin City, Nigeria. Nigerian Hospital Practice. 2009; 3: 12. DOI: 10.4314/nhp.v3i1-2.45616
  99. Veronese JP, Wallis L, Allgaier R, Botha R. Cardiopulmonary resuscitation by Emergency Medical Services in South Africa: Barriers to achieving high quality performance. Revue africaine de la medecine d’urgence. [African Journal of Emergency Medicine]. 2018; 8(1): 611. DOI: 10.1016/j.afjem.2017.08.005
  100. Zha Y, Ariyo M, Olaniran O, Ariyo P, Lyon C, Kalu Q, et al. Cardiopulmonary resuscitation capacity in referral hospitals in Nigeria: Understanding the global health disparity in resuscitation medicine. Journal of the National Medical Association. 2018; 110(4): 40713. DOI: 10.1016/j.jnma.2017.09.002
  101. Brink PA, Crotti L, Corfield V, Goosen A, Durrheim G, Hedley P, et al. Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. Circulation. 2005; 112(17): 260210. DOI: 10.1161/CIRCULATIONAHA.105.572453
  102. Smith C, Feldman C, Reyneke J, Promnitz DA, Kallenbach JM, Zwi S. Sarcoidosis in Johannesburg—A comparative study of black and white patients. Suid-Afrikaanse tydskrif vir geneeskunde. [South African Medical Journal]. 1991; 80(9): 4237.
  103. Morar R, Feldman C. Sarcoidosis in Johannesburg, South Africa: A retrospective study. European Respiratory Journal. 2015; 46(suppl 59): PA841. DOI: 10.1183/13993003.congress-2015.PA841
  104. Awotedu AA, George AO, Oluboyo PO, Alabi GO, Onadeko BO, Ogunseyinde O, et al. Sarcoidosis in Africans: 12 cases with histological confirmation from Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1987; 81(6): 10279. DOI: 10.1016/0035-9203(87)90387-7
  105. Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: Calendar year 2009—A World Society of Arrhythmia’s project. Pacing and Clinical Electrophysiology: PACE. 2011; 34(8): 101327. DOI: 10.1111/j.1540-8159.2011.03150.x
  106. Sani MU, Mayosi BM. The Pacemaker and ICD Reuse Programme of the Pan-African Society of Cardiology. Heart (British Cardiac Society). 2017; 103(23): 18445. DOI: 10.1136/heartjnl-2017-311462
  107. Jama ZV, Chin A, Badri M, Mayosi BM. Performance of re-used pacemakers and implantable cardioverter defibrillators compared with new devices at Groote Schuur Hospital in Cape Town, South Africa. Cardiovascular Journal of Africa. 2015; 26(4): 1817. DOI: 10.5830/CVJA-2015-048
  108. Tchoumi JT, Ambassa JC, Mvondo C, Butera G. Challenges in cardiac pacing activities in a subsaharan tertiairy centre. Archives of Cardiovascular Diseases Supplements. 2019; 11(1): 334. DOI: 10.1016/j.acvdsp.2018.10.068
  109. Adoubi AK, Diby F, Ndjessan JJ, Gnaba A, Yangni-Angaté HK. Prognosis of heart failure in patients with conventional cardiac pacing. A monocentric study in sub-Saharan Africa. Global Heart. 2018; 13(4): 398. DOI: 10.1016/j.gheart.2018.09.080
  110. Jouven X, Sagnol P, Marijon E. Cardiac pacing in sub-Saharan Africa—Cardiology and development experience. Sang Thrombose Vaisseaux. 2016; 28(5): 22530. DOI: 10.1684/stv.2016.0952
  111. Ikama SM, Makani J, Jouven X, Kimbally-Kaky G. Permanent cardiac pacing: First Congolese experiment. The Pan African Medical Journal. 2015; 20: 381. DOI: 10.11604/pamj.2015.20.381.5803
  112. Falase B, Sanusi M, Johnson A, Akinrinlola F, Ajayi R, Oke D. Analysis of a five year experience of permanent pacemaker implantation at a Nigerian Teaching Hospital: Need for a national database. The Pan African Medical Journal. 2013; 16: 16. DOI: 10.11604/pamj.2013.16.16.2644
  113. Kane AD, Ndiaye MB, Pessinaba S, Mbaye A, Bodian M, Driouch ME, et al. Infections secondary to pacemaker implantation: A synopsis of six cases. Cardiovascular Journal of Africa. 2012; 23(10): e14. DOI: 10.5830/CVJA-2012-035
  114. Millar RN. 1998 survey of cardiac pacing in South Africa—Report of the working group on registries of the cardiac arrhythmia society of South Africa (CASSA). Suid-Afrikaanse tydskrif vir geneeskunde. [South African Medical Journal]. 2001; 91(10): 8736.
  115. Mayosi BM, Little F, Millar RN. Long-term survival after permanent pacemaker implantation in young adults: 30 year experience. Pacing and Clinical Electrophysiology: PACE. 1999; 22(3): 40712. DOI: 10.1111/j.1540-8159.1999.tb00468.x
  116. Thiam M, Fall PD, Gning SB, Ott D, Gueye PM, Wade B, et al. Annales de cardiologie et d’angeiologie. Cardiac pacing in West Africa: Feasibility, problems, and perspectives. 2003; 52(4): 2124. DOI: 10.1016/S0003-3928(02)00189-0
  117. Diop IB, Ba S, Underwood P, Diack B, Damourou JM, Kane A, et al. Permanent cardiac stimulation in Senegal: Preliminary experience at the Cardiology Clinic of Dakar. Dakar Medical. 2000; 45(1): 1014.
  118. dos Santos LA, Agathangelou NE, Taams MA, Lewis BS. Permanent cardiac pacing in South African Blacks. Suid-Afrikaanse tydskrif vir geneeskunde. [South African Medical Journal]. 1982; 61(25): 9479.
  119. Ekpe EE, Aghaji MA, Edaigbini SA, Onwuta CN. Cardiac pacemaker treatment of heart block in Enugu a 5-year review. Nigerian Journal of Medicine: Journal of the National Association of Resident Doctors of Nigeria. 2008; 17(1): 712. DOI: 10.4314/njm.v17i1.37346
  120. Varwani MH, Jeilan M. ICD implantation in post MI LV dysfunction: A sub Saharan Centre experience. Cardiovascular Journal of Africa. 2018; 29: 12. DOI: 10.5830/CVJA-2018-066
  121. Imazio M, Gaita F, LeWinter M. Evaluation and treatment of pericarditis: A systematic review. Jama. 2015; 314(14): 1498506. DOI: 10.1001/jama.2015.12763
  122. Noubiap JJ, Nyaga UF. A review of the epidemiology of atrial fibrillation in sub-Saharan Africa. Journal of Cardiovascular Electrophysiology. 2019; 30(12): 300616. DOI: 10.1111/jce.14222
  123. Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart disease and stroke statistics—2018 Update: A report from the American Heart Association. Circulation. 2018; 137(12): e67e492. DOI: 10.1161/CIR.0000000000000573
  124. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Annals of Internal Medicine. 2007; 146(12): 85767. DOI: 10.7326/0003-4819-146-12-200706190-00007
  125. Wallentin L, Lopes RD, Hanna M, Thomas L, Hellkamp A, Nepal S, et al. Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. Circulation. 2013; 127(22): 216676. DOI: 10.1161/CIRCULATIONAHA.112.142158
  126. Kakkar AK, Mueller I, Bassand JP, Fitzmaurice DA, Goldhaber SZ, Goto S, et al. Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: Perspectives from the international, observational, prospective GARFIELD registry. PloS One. 2013; 8(5): e63479. DOI: 10.1371/journal.pone.0063479
  127. AlTurki A, Proietti R, Dawas A, Alturki H, Huynh T, Essebag V. Catheter ablation for atrial fibrillation in heart failure with reduced ejection fraction: A systematic review and meta-analysis of randomized controlled trials. BMC Cardiovascular Disorders. 2019; 19(1): 18. DOI: 10.1186/s12872-019-0998-2
  128. Patel D, Hasselblad V, Jackson KP, Pokorney SD, Daubert JP, Al-Khatib SM. Catheter ablation for ventricular tachycardia (VT) in patients with ischemic heart disease: A systematic review and a meta-analysis of randomized controlled trials. Journal of Interventional Cardiac Electrophysiology: An International Journal of Arrhythmias and Pacing. 2016; 45(2): 1117. DOI: 10.1007/s10840-015-0083-4
  129. Porter MJ, Morton JB, Denman R, Lin AC, Tierney S, Santucci PA, et al. Influence of age and gender on the mechanism of supraventricular tachycardia. Heart Rhythm. 2004; 1(4): 3936. DOI: 10.1016/j.hrthm.2004.05.007
  130. Page Richard L, Joglar José A, Caldwell Mary A, Calkins H, Conti Jamie B, Deal Barbara J, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia. Circulation. 2016; 133(14): e506e74.
  131. Berdowski J, Berg RA, Tijssen JG, Koster RW. Global incidences of out-of-hospital cardiac arrest and survival rates: Systematic review of 67 prospective studies. Resuscitation. 2010; 81(11): 147987. DOI: 10.1016/j.resuscitation.2010.08.006
  132. Mirsaeidi M, Machado RF, Schraufnagel D, Sweiss NJ, Baughman RP. Racial difference in sarcoidosis mortality in the United States. Chest. 2015; 147(2): 43849. DOI: 10.1378/chest.14-1120
  133. Birnie DH, Kandolin R, Nery PB, Kupari M. Cardiac manifestations of sarcoidosis: Diagnosis and management. European Heart Journal. 2017; 38(35): 266370.
  134. Adabag AS, Luepker RV, Roger VL, Gersh BJ. Sudden cardiac death: Epidemiology and risk factors. Nature Reviews Cardiology. 2010; 7(4): 21625. DOI: 10.1038/nrcardio.2010.3
  135. Chelly J, Mongardon N, Dumas F, Varenne O, Spaulding C, Vignaux O, et al. Benefit of an early and systematic imaging procedure after cardiac arrest: Insights from the PROCAT (Parisian Region Out of Hospital Cardiac Arrest) registry. Resuscitation. 2012; 83(12): 144450. DOI: 10.1016/j.resuscitation.2012.08.321
  136. Olasveengen TM, de Caen AR, Mancini ME, Maconochie IK, Aickin R, Atkins DL, et al. 2017 International consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations summary. Circulation. 2017; 136(23): e424e40. DOI: 10.1161/CIR.0000000000000553
  137. Hazinski MF, Idris AH, Kerber RE, Epstein A, Atkins D, Tang W, et al. Lay rescuer automated external defibrillator (“public access defibrillation”) programs: Lessons learned from an international multicenter trial: Advisory statement from the American Heart Association Emergency Cardiovascular Committee; The Council on Cardiopulmonary, Perioperative, and Critical Care; and the Council on Clinical Cardiology. Circulation. 2005; 111(24): 333640. DOI: 10.1161/CIRCULATIONAHA.105.165674
  138. Runge MW, Baman TS, Davis S, Weatherwax K, Goldman E, Eagle KA, et al. Pacemaker recycling: A notion whose time has come. World Journal of Cardiology. 2017; 9(4): 296303. DOI: 10.4330/wjc.v9.i4.296
  139. Raatikainen MJP, Arnar DO, Merkely B, Nielsen JC, Hindricks G, Heidbuchel H, et al. A decade of information on the use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European society of cardiology countries: 2017 report from the European Heart Rhythm Association. Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. 2017; 19(suppl_2): ii1ii90. DOI: 10.1093/europace/eux258
  140. Jensen PN, Gronroos NN, Chen LY, Folsom AR, deFilippi C, Heckbert SR, et al. Incidence of and risk factors for sick sinus syndrome in the general population. Journal of the American College of Cardiology. 2014; 64(6): 5318. DOI: 10.1016/j.jacc.2014.03.056
  141. Wunderly K, Yousef Z, Bonny A, Weatherwax KJ, Lavan B, Allmendinger C, et al. Using reconditioned pacemakers to treat bradycardia in Africa. Nature Reviews Cardiology. 2018; 15(12): 7256. DOI: 10.1038/s41569-018-0076-y
  142. Ochasi A, Clark P. Reuse of pacemakers in Ghana and Nigeria: Medical, legal, cultural, and ethical perspectives. Developing World Bioethics. 2015; 15(3): 12533. DOI: 10.1111/dewb.12047
  143. Baman TS, Meier P, Romero J, Gakenheimer L, Kirkpatrick JN, Sovitch P, et al. Safety of pacemaker reuse: A meta-analysis with implications for underserved nations. Circulation Arrhythmia and Electrophysiology. 2011; 4(3): 31823. DOI: 10.1161/CIRCEP.110.960112
  144. Hughey AB, Desai N, Baman TS, Gakenheimer L, Hagan L, Kirkpatrick JN, et al. Heart Rhythm Society members’ views on pacemaker and implantable cardioverter-defibrillator reuse. Pacing and Clinical Electrophysiology: PACE. 2014; 37(8): 96977. DOI: 10.1111/pace.12418
  145. World Health Organization. Public financing for health in Africa: From Abuja to the SDGs 2016. https://www.who.int/health_financing/documents/public-financing-africa/en/.
  146. World Health Organization. State of health financing in the African region. Brazzaville: WHO Africa 2013. https://www.afro.who.int/sites/default/files/2017-06/state-of-health-financing-afro.pdf.
  147. Kakou-Guikahue M, N’Guetta R, Anzouan-Kacou JB, Kramoh E, N’Dori R, Ba SA, et al. Optimizing the management of acute coronary syndromes in sub-Saharan Africa: A statement from the AFRICARDIO 2015 Consensus Team. Archives of Cardiovascular Diseases. 2016; 109(6–7): 37683. DOI: 10.1016/j.acvd.2015.12.005
  148. Carlson S, Duber HC, Achan J, Ikilezi G, Mokdad AH, Stergachis A, et al. Capacity for diagnosis and treatment of heart failure in sub-Saharan Africa. Heart (British Cardiac Society). 2017; 103(23): 18749. DOI: 10.1136/heartjnl-2016-310913
  149. Agyepong IA, Sewankambo N, Binagwaho A, Coll-Seck AM, Corrah T, Ezeh A, et al. The path to longer and healthier lives for all Africans by 2030: the Lancet Commission on the future of health in sub-Saharan Africa. Lancet (London, England). 2018; 390(10114): 280359. DOI: 10.1016/S0140-6736(17)31509-X
  150. Sliwa K, Zuhlke L, Kleinloog R, Doubell A, Ebrahim I, Essop M, et al. Cardiology-cardiothoracic subspeciality training in South Africa: A position paper of the South Africa Heart Association. Cardiovascular Journal of Africa. 2016; 27(3): 18893. DOI: 10.5830/CVJA-2016-063
DOI: https://doi.org/10.5334/gh.808 | Journal eISSN: 2211-8179
Language: English
Submitted on: Apr 17, 2020
|
Accepted on: Apr 17, 2020
|
Published on: May 8, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2020 Matthew F. Yuyun, Aimé Bonny, G. André Ng, Karen Sliwa, Andre Pascal Kengne, Ashley Chin, Ana Olga Mocumbi, Marcus Ngantcha, Olujimi A. Ajijola, Gene Bukhman, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.